Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach: macro science. Palette: bold color field, warm. An extreme close-up of a human iris and pupil photographed from straight on, with a shallow depth of field. The sharp focus sits on the fine radial fibers of the iris, which are amber and honey brown. A single soft ring light reflects as a small crisp circle in the pupil. Behind the eye, out of focus, the skin and lashes fall away into a saturated mustard-yellow backdrop that fills the frame. A thin curved sliver of electric green light, like a reflection on the cornea's edge, is the only cool accent. The texture is real: tiny blood vessels in the sclera, individual lash hairs, moist highlights. The mood is clear, attentive and hopeful, clinical but warm. The composition is landscape, with the eye placed right of center and open space on the left.
Supplements

Trio Polifenol Iki Nyilikake Deposit Drusen AMD Mata 13 % ing Uji Manungsa

Nova Chen · · 4 min read
#clinical trial #quercetin #curcumin #amd #resveratrol #drusen #eye health

Trio Polifenol Iki Nyilikake Deposit Drusen AMD Mata 13 % ing Uji Manungsa

Drusen, endapan kuning sing nglumpuk ing ngisor retina, iku salah siji pratanda khas degenerasi makula amarga umur (AMD). Sawisé muncul, drusen cenderung nambah ukuran lan jumlahé. Ing trial manungsa anyar, kombinasi resveratrol, quercetin, lan curcumin (RQC) kabukti bisa ngurangi volume drusen sing bisa diukur sajrone rong taun. Asilé menarik, nanging asalé saka studi cilik sing open‑label, mula waca rinciané sadurunge langsung ngoyak suplemen iki.

Iki riset klinis manungsa, ora mung studi ing tikus utawa cawan petri. Nanging minangka trial fase awal kanthi watesan desain sing jelas, kaya sing dijlèntrèhaké ing ngisor iki.

Apa sing Diteliti Peneliti?

Studi iki, diterbitaké ing Translational Vision Science & Technology déning Pfahler lan Knepper (University of Illinois Chicago lan Northwestern), yaiku trial open‑label, acak fase 2a. Pasien karo AMD awal utawa menengah diacak 2:1 kanggo nampa salah siji saka:

  • Kombinasi lisan resveratrol, quercetin, lan curcumin (RQC), utawa
  • Curcumin lisan dhéwé

Perawatan dilakokaké 24 sasi. Hasil utama yaiku owah‑owahan volume drusen tengah saka wiwitan, diukur nganggo spectral‑domain optical coherence tomography (SD‑OCT), metode citra retina resolusi tinggi sing dadi standar. Hasil sekunder kalebu volume lan jumlah drusen miturut ukuran wiwitan, respon drusen individu, best‑corrected visual acuity (BCVA), frekuensi kebutaan, progresi menyang AMD lanjut, lan keamanan.

Angka‑angka Utama

38 pasien kalebu ing analisis pungkasan. Sawisé 24 sasi:

  • Volume drusen tengah mudun 13,4 % ing grup RQC lan mundhak 6,9 % ing grup sing mung nggunakaké curcumin (P = 0,02).
  • BCVA mundhak 0,8 huruf ing grup RQC, nanging mudhun 2,1 huruf ing grup curcumin (P = 0,08); mula bedane iki ora nyampe signifikansi statistik.
  • Kehilangan penglihatan ringan lan moderat luwih sithik ing grup RQC. Abstrak ora nyedhiyakake angka persis.
  • Progresi menyang AMD lanjut kedadeyan ing 3,7 % peserta RQC lan 2,3 % mata sing layak ing grup curcumin.

Penulis nyimpulaké yèn RQC gegandhèngan karo pangurangan volume drusen, tingkat progresi AMD lanjut sing sithik, lan ketajaman visual sing tetep sajrone 24 sasi.

Napa Drusen Penting?

Drusen dadi tanda risiko visual lan progresi AMD. Ndelok drusen nyusut ing citra OCT iku menarik amarga nuduhaké potensi intervensi ing tahap awal lan menengah penyakit. Penulis nyatakaké karya iki minangka bukti pendahuluan yèn terapi lisan bisa nyuda beban drusen lan pantes diteliti luwih lanjut.

Nanging nyusuté drusen ora padha karo perlindungan pandelengan sing wis dibuktekaké. Data visual saka studi iki ora signifikan sacara statistik, lan volume drusen mung minangka penanda pangganti (surrogate). Apa nyuda drusen bener‑bener bakal ngowahi asil jangka panjang isih dadi pitakonan sing durung dijawab.

Cetakan Cilik: Watesan Sing Kudu Dikenal

  1. Sampel cilik. Mung 38 pasien sing dianalisis. Trial cilik bisa ngasilaké asil sing fluktuatif lan ora mesthi bisa didadèkaké basis kanggo rekomendasi klinis.
  2. Ora ana kelompok plasebo. Pembandingé mung curcumin, dudu plasebo. Dadi trial iki mbandhingaké RQC karo salah siji komponèné dhéwé, ora karo “ora nindakake apa‑apa”. Pertumbuhan drusen ing grup curcumin (+6,9 %) uga ora mesthi nglambangaké progresi alami.
  3. Desain open‑label. Peserta lan dokter ngerti sapa sing nampa apa, sing bisa nambah bias, sanajan pangukuran SD‑OCT relatif objektif.
  4. Hasil pandelengan ora signifikan. Bedane BCVA (P = 0,08) mung nuduhaké tren, ora manfaat sing dipastikan. Tambahan 0,8 huruf vs mudhun 2,1 huruf uga cilik banget.
  5. Fase 2a. Fase iki dirancang kanggo nliti sinyal lan kelayakan, dudu kanggo netepaké efektivitas.
  6. Rincian sing kurang ing abstrak. Dosis, formulasi, lan temuan keamanan ora dilaporaké, mula ora bisa dinilai mung saka ringkesan.

Posisi Karo AREDS2

Standar suplemen sing wis diterima kanggo AMD menengah tetep formulasi AREDS2, sing dibangun saka bukti trial skala gedhé. Ora ana sing ing studi iki nggantèkaké AREDS2. Trial iki ora mbandhingaké RQC karo AREDS2, mula ora bisa ngandhani apa kombinasi polifenol iki luwih apik, luwih ala, utawa cukup melengkapi. Saiki RQC mung sinyal riset, dudu rekomendasi kanggo ngowahi regimen suplemen.

Ringkesan Praktis

  • Dosis: Abstrak ora nyebutaké dosis utawa formulasi, mula ora bisa diwenehake ing kéné. Aja nebak adhedhasar label over‑the‑counter. Penyerapane lan dosis senyawa iki béda‑béda antar produk, lan regimen trial bisa ora cocog karo sing ana ing toko.
  • Wektu: Intervensi iki dilakokaké 24 sasi kanthi pangobatan lisan. Efek sing katon muncul mung sawise wektu dawa kuwi, ora sakwisé sawetara minggu.
  • Sapa sing relevan: Peserta nduwèni AMD awal utawa menengah. Iki siji‑sijine populasi sing bukti iki bisa digunaake, lan malah ngono isih pendahuluan. Yen sampeyan nduwèni AMD, rembugan riset iki karo dokter mripat, sing bisa nimbang karo AREDS2 lan profil risiko pribadi sampeyan.
  • Sapa sing kudu ngindhari eksperimen dhewe:
    • Pasien AMD lanjut, sing ora dadi target studi iki lan butuh perawatan khusus.
    • Wong‑wong sing arep ngurangi monitoring utawa perawatan sing disaranake kanthi ngandelake suplemen iki.
    • Pasien sing lagi njupuk obat resep, utamane antikoagulan, utawa sing lagi hamil utawa nduwèni kondisi kronis.
    • Sapa wae sing ngarep‑arep solusi sing wis teruji. Iki durung dadi.

Simpulan

Kombinasi resveratrol, quercetin, lan curcumin ditemokake gegandhèngan karo penurunan volume drusen tengah sing signifikan sacara statistik (-13,4 % vs +6,9 %, P = 0,02) ing trial acak 24 sasi kanthi 38 wong sing nduwèni AMD awal utawa menengah. Manfaat pandelengan ora nganti signifikan, ora ana kelompok plasebo, lan desainé open‑label. Iki asil sing ngajokaké hipotesis menarik lan mbutuhake trial gedhé, buta, lan kontrol plasebo, dudu alesan kanggo ngowahi rutinitas perawatan mripat dhewe.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: conceptual metaphor. Palette: D, bold color field. Subject: a single old-fashioned mechanical light switch, photographed straight on, with its toggle stuck halfway between on and off. It is mounted on a saturated mustard-yellow painted wall. A thin electric green (#00e676) glow leaks from the gap behind the toggle and casts a small green rim onto the plate. Beside it, a row of six small matte black tally marks is scratched into the paint, with the third and fifth marks fainter and partly worn, hinting at inconsistent results across days. Camera: slightly low, eye-level angle with a 50mm lens, shallow depth of field, and the switch placed on the right third of the frame. Lighting: hard directional side light from the left casts crisp, warm-neutral shadows with no blue cast. The wall texture and brushstrokes are visible. Mood: curious, skeptical, and measured. The scene suggests a mechanism that is partly engaged.
longevity

Diet Mirip Puasa Ngedongkrak Autophagy Manungsa—Nanging Ora Saben Wektu

BY HELIX WARD ·

Apa diet mirip puasa (FMD) pancen isa ngaktifake proses pembersihan sel dhewe, utawa mung fenomena ing tikus? Sawijining uji coba acak pilot sing melu 30 relawan sehat ngetes ProLon lan FMD2 dibandhingake karo grup kontrol. Sawisé kira‑kira enem dina, loro grup nuduhaké owah‑owahan ing aliran autophagy, bobot awak, glukosa, keton, lan resistensi insulin. Nanging perbedaan kuwi ora konsisten ing saben wektu, lan uji coba cilik iki disponsori dening produsen ProLon. Kene carane protokol ditindakake, apa asil sing ditemokaké, lan sapa sing kudu mikir kaping pindho sadurunge nyoba.
Approach: conceptual metaphor. Palette: bold color field (saturated orange). A single clear glass of water sits on a seamless saturated tangerine-orange backdrop, shot from a low three-quarter angle at eye level. Dense streams of tiny hydrogen bubbles rise through the water, but at the surface the glass has cracked in a thin, sharp fracture line that runs up the side, as if the "healthy" promise has split. A few droplets hang mid-air beside the crack. Hard directional studio light from the upper left casts a crisp, elongated shadow across the orange floor, and bright caustic highlights bend through the water. A tiny electric green (#00e676) reflection glints along the rim of the glass. The look is clean, graphic and photorealistic, with shallow depth of field. The mood is skeptical and tense, with a quiet sense of irony.
supplements

Banyu Hidrogen Gagal: Penanda Kerusakan Oksidatif Nambah ing Trial

BY HELIX WARD ·

Banyu sing sugih hidrogen dipasarkan minangka cara gampang nglawan radikal bebas, nanging trial acak sing diblindhingi ing pasien penyakit gunung kronis nampilaké asil sing mbalik. Sawisé 8 minggu ngombé 990 mL saben dina, kelompok hidrogen malah nambah kadar MDA, penanda kerusakan oksidatif, luwih dhuwur tinimbang plasebo (+2,11, p < 0,001). Kapasitas antioksidan total uga munggah, lan kenaikan MDA luwih gedhé ing wong kanthi BMI ≥ 24. Efek samping luwih asring kedadeyan ing kelompok banyu hidrogen (50 % vs 37 %), paling umum pusing. Amarga trial iki cilik lan mung meliputi pasien ing dhuwur, asilé kudu dipahami watesé.
Approach: Macro science. Palette: D, bold color field. Extreme close-up microscopy-style image of a dense cluster of oval, rod-shaped bacteria with a slightly mucous, glossy membrane texture, shot from a shallow top-down angle with a razor-thin focal plane. Most of the colony sits in the sharp center, softening into creamy blur at the edges. The cells are warm ivory with subtle translucent depth, resting on a saturated tomato-red backdrop. A scattering of sparser, isolated cells on one side suggests "low baseline" and hints at the subgroup story. One or two cells carry a faint electric green (#00e676) fluorescent rim glow. Lighting is soft, directional studio light with gentle specular highlights on the cell walls and clean shadows in warm red tones. Mood: curious, precise, quietly skeptical, with a vivid but grounded look. No text and no blue cast.
supplements

Akkermansia Gagal Nggawe Tujuan Utama—Nanging Ana ing Wong sing Kekurangan

BY NOVA CHEN ·

Bakteri usus sing dipasteurisasi lan dipromosikaké minangka “penambah GLP‑1 alami” anyar gagal nggayuh tujuan utama ing uji coba double‑blind karo 142 peserta. Nanging analisis eksploratori nuduhaké kenaikan GLP‑1 lan perbaikan sensitivitas insulin ing wong sing wiwitane nduwèni tingkat Akkermansia sing rendah. Iki mung hipotesis lan isih butuh konfirmasi independen.
Approach: Macro science, with the human outcome as a quiet secondary cue. Palette: C (Natural). Extreme macro photograph of a halved red onion and fresh celery leaves, the real dietary sources of isorhamnetin and luteolin. The onion's glossy magenta-violet layers and translucent cell walls fill the left two-thirds of the frame, with fine droplets of juice catching the light. A few crisp green celery leaves and a sprig of dried parsley rest in soft focus to the right. Shot at a slight low angle, shallow depth of field, 100mm macro look. Soft morning daylight from a window behind and to the side gives a warm rim light and gentle translucency through the onion layers. The palette is earthy: plum, sage green, and warm wood tones, with one small electric green highlight on a celery leaf edge. The mood is calm, fresh, and quietly curious, with a hint of rest.
supplements

Flavonoid Sing Ora Kaping Digatekake Sing Nggandhengake karo Turu Luwih Apik, Dudu Quercetin

BY NOVA CHEN ·

Saben wong padha ngomong babagan quercetin, nanging analisis survei gedhé ing AS nuduhaké loro flavonoid sing luwih cilik yaiku isorhamnetin lan luteolin, sing kagandhèngan karo turu luwih apik. Wong sing ngonsumsi isorhamnetin paling akèh nduwèni risiko gangguan turu kira‑kira 25 % luwih murah lan nglaporaké turu luwih suwe. Luteolin mung nuduhaké hubungan sing luwih sithik, watara 15 % luwih murah. Nanging iki mung studi potong‑potong saka 10 162 wong diwasa adhedhasar cathetan panganan, dudu suplemen, mula ora bisa mbuktèkaké sebab‑akibat. Ing ngisor iki angka‑angkaé, apa sing ora dituduhaké, lan apa sing bisa dijupuk saka asil iki.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文